Liz sells GSK 53.87: Anoro(R) Ellipta(R) (Umeclidinium/Vilanterol) Gains Approval in Japan for the Treatment of COPD
LONDON, UNITED KINGDOM and SOUTH SAN FRANCISCO, CA-- (Marketwired) -- 07/07/14 -- GlaxoSmithKline plc (GLAXF) (LSE: GSK) (NYSE: GSK) and Theravance, Inc. (THRX) today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved .. ...
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home